The Latest Breaking News from MHRA

The trick works for drugs including paracetamol, ibuprofen and hayfever tablets

Overactive bladder (OAB) silently impacts the lives of countless women in the UK by causing an uncontrollable and distressing urge to urinate during the day and through the night

One in six women have symptoms associated with an overactive bladder

Women with the condition are being urged to take part in a consultation on whether to make a treatment available without prescription.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new COVID vaccine. VLA2001 is manufactured by French pharmaceutical company Valneva for use in the UK and was approved on April 14 for use in adults between the ages of 18 and 50 for first and second doses.

Pregabalin is used to treat epilepsy, anxiety and nerve pain.

It is the sixth Covid-19 vaccine to be granted an MHRA authorisation for use in Britain

Drug used to treat epilepsy and bipolar disorder is being given to pregnant women despite risks, data shows

Sodium valproate, associated with birth defects, reportedly being prescribed without proper warnings

Concerns over potential conflicts of interest lead to calls for regulator’s policy to be strengthened

Plans to hire 200 workers at the Livingston plant were put into question last year after Boris Johnson pulled the plug on a £1billion contract to buy 100million doses of the vaccine.